by Yannis Natsis | Dec 17, 2020 | COVID-19, Universal Access and Affordable Medicines | Latest Developments
39 civil society organisations including EPHA are calling on the European Commission and EU national governments to ensure a maximum degree of transparency in the EU’s exchanges, negotiations and deals with pharmaceutical companies over COVID19 vaccines, proposing a...
by Yannis Natsis | Nov 14, 2020 | Universal Access and Affordable Medicines | Latest Developments
Pharmaceutical policies and access to medicines top the policy agenda especially as the COVID19 challenges bring issues such as transparency in pharma, affordability of therapeutics, role of public support in biomedical innovation to the forefront. It is now more...
by European Public Health Alliance | Nov 10, 2020 | Universal Access and Affordable Medicines | Latest Developments, Universal Access and Affordable Medicines | Publications
What do we know when a new medicine is approved? What are the regulatory requirements for new medicines? What happens once a new drug is on the market? Following the first of the EPHA #A2MDialogues, our panelists Andrea Cipriani, Lydia Meheus, Huseyin Naci and Beate...
by European Public Health Alliance | Sep 18, 2020 | COVID-19, Universal Access and Affordable Medicines | Latest Developments
The COVID-19 crisis represents an unprecedented challenge for societies in the European Union as well as at a global level. The European vaccines strategy’s Advance Purchase Agreements (APAs) mechanism has been used by the EU to procure vaccines for COVID-19. We...
by European Public Health Alliance | Sep 18, 2020 | Universal Access and Affordable Medicines | Latest Developments
Our organisations, representing patients, consumers, healthcare professionals and public health interests, very much welcome the INI report on the shortage of medicines voted by the European Parliament on September 17th 2020. We remind that shortages of medicines...
by European Public Health Alliance | Jul 13, 2020 | Universal Access and Affordable Medicines | Latest Developments, Universal Access and Affordable Medicines | Publications
The EU must ensure access to affordable and quality medicines in Europe whilst guaranteeing everyone’s right to a healthy and sustainable environment. Human medicine is not an ordinary commodity – public interest and public health should prevail as leading...